Investigating a novel phosphoinositide-lysosomal signalling axis for pancreatic cancer therapy

研究用于胰腺癌治疗的新型磷酸肌醇-溶酶体信号轴

• 批准号: 477270
• 负责人: Salmena Leonardo L
• 金额: $ 7.29万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-10-01 至 2023-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=477270&lang=en
• 关键词: Chemoresistance; Inpp4b; Lysosome; Metastasis; Pancreas; Phosphoinositide Signalling

Despite improvements in our understanding of pancreatic cancer biology in the last two decades, this disease is still among the most devastating of all cancers. It is clear that researchers still have much to learn about what triggers pancreatic cancers t

尽管在过去的二十年里，我们对胰腺癌生物学的理解有所提高，但这种疾病仍然是所有癌症中最具破坏性的。很明显，研究人员仍然有很多东西要了解是什么引发胰腺癌。